Navigation Links
Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems
Date:1/24/2013

health systems," said Ashoka President Diana Wells . "We have found that in tackling health from a systems level, most of our social entrepreneurs are finding ways to 1) deliver unlikely allies to solve the healthcare practitioner shortage  or 2) are innovating new delivery systems which can reach low income populations in both urban and rural areas.  We are excited to partner with Boehringer Ingelheim once again to tap the transformative power of social entrepreneurship and to solve one of the most critical issues that is confronting society today."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing, and marketing novel products of high therapeutic value for human and veterinary medicine.

Social responsibility is a core element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of its global operations. Mutual cooperation and respect, as well as environmental protection and sustainability, are intrinsic values of all of Boehringer Ingelheim's endeavors.

For more information please visit www.boehringer-ingelheim.com

About Ashoka Changemakers

Ashoka Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social
'/>"/>

SOURCE Ashoka Changemakers
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... MARLBOROUGH, Mass. , Aug. 29, 2014 /PRNewswire/ ... ) prospective, multinational study on stent removability and ... strictures has been published in the August issue ... The multinational study 1 is being conducted ... removal of fully covered self-expanding metal stents (FCSEMS) ...
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
(Date:8/29/2014)... JORDAN, Utah , Aug. 29, 2014  BC ... Solutions, has acquired Polaris Medical Imaging, a leader in ... scanners. This strategic acquisition allows BC Technical to continue ... capabilities, specifically within MR and CT modalities. ... cost service," said Mark Alvarez , president and ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2BC Technical Acquires Polaris Medical Imaging 2
... study broadens Phase 3 clinical program to further evaluate the ... April 15 Pfizer (NYSE: PFE ) and ... announced the initiation of a 12-month, Phase 3 clinical trial ... CONCERT, is designed to evaluate the safety and efficacy of ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) today announced that ... study to evaluate the safety and tolerability of PCI-32765,an ... Btk,as a potential treatment for patients with relapsed or ... first Btk selective inhibitor to,be tested in humans, and ...
Cached Medicine Technology:Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 2Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 3Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5
(Date:8/31/2014)... GoDaddy, IX Web Hosting and Bluehost are popular ... hosting, which is the method of partitioning a ... which has the appearance and capabilities of running ... compared many professional web hosting suppliers and announced ... hosting suppliers in the global market. , GoDaddy ...
(Date:8/31/2014)... In order to celebrate the coming of autumn, Guangdong ... and launched a big promotion. Now, all the global clients ... company’s new cars are made with great materials. FODAY Automobile ... As a matter of fact, it is providing big discounts ... in need of cheap cars can visit its website for ...
(Date:8/31/2014)... Orem, UT (PRWEB) August 31, 2014 ... a number of states have proposed legislation to require ... so consumers can make informed purchasing decisions that affect ... As an industry leader advocating for stringent measures to ... launch of its “Information, Communication, Engagement” (I.C.E.) initiative with ...
(Date:8/31/2014)... Tickets for Brazil vs. Ecuador at MetLife Stadium ... This is great news for diehard soccer fans who would have ... the delight of soccer fans in the Tri-State area these two ... September 9th. , MetLife Stadium is the home field ... the National Football League. The venue opened in 2010 and has ...
(Date:8/31/2014)... UWDress.com, a renowned wedding dress manufacturer and retailer, ... elegant formal bridesmaid dresses today. Moreover, the ... quality special occasion outfits. All its current and prospective ... , Along with the greatly discounted prices, all ... promotional formal bridesmaid outfits are offered in over 20 ...
Breaking Medicine News(10 mins):Health News:GoDaddy, IX Web Hosting and Bluehost Are Awarded As Hosting Experts by Top10BestSEOHosting.com 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3Health News:Brazil vs. Ecuador Tickets MetLife Stadium: Ticket Down Slashes Ticket Prices on Ecuador vs. Brazil Tickets in East Rutherford, NJ at the MetLife Stadium 2Health News:Elegant Formal Bridesmaid Dresses Today Unveiled By UWDress.com 2
... A steady reduction in overall cancer death rates translates ... between 1990 and 2007, according to the latest statistics ... Statistics 2011, and its companion consumer publication Cancer Facts ... all segments of the population equally. A special section ...
... poorer dental care than white Americans, even when ... understand why this is so, researchers at Columbia ... College of Dental Medicine, surveyed African American adults ... gum disease. Their findings provide insights into why ...
... death across a population has evolved in recent decades. ... attack and cancer, the role of behavioral factorsincluding smoking, ... 1990s. More recent research has begun to look ... In the first comprehensive analysis of such studies, researchers ...
... , THURSDAY, June 16 (HealthDay News) -- No ... percent of the officers from the New York Police Department,s ... on the World Trade Center, according to a new study. ... from 206 officers who responded to the attack and found ...
... (June 16, 2011) -- As many as 15 percent ... veins in the testicles. There is new evidence that ... infertility, interfere with the production of testosterone -- a ... good news too: Microsurgery can increase testosterone levels in ...
... director of Medical Student Education at Boston University ... the first physician to receive the American Association ... Career Award for her continued efforts to improve ... intellectual and developmental disabilities (I/DD). The AAIDD presented ...
Cached Medicine News:Health News:American Cancer Society report finds continued progress in reducing cancer mortality 2Health News:American Cancer Society report finds continued progress in reducing cancer mortality 3Health News:American Cancer Society report finds continued progress in reducing cancer mortality 4Health News:Why disparities in dental care persist for African-Americans even when they have insurance coverage 2Health News:Why disparities in dental care persist for African-Americans even when they have insurance coverage 3Health News:How many US deaths are caused by poverty, low levels of education and other social factors? 2Health News:Lung Health of Police Responders From 9/11 Called 'Encouraging' 2Health News:Low testosterone linked to varicoceles 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: